Welcome to the e-CCO Library!

search
Search by: 
Year: Category:
39: Announcement of ECCO Fellowship & Grants 2016
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Rogler G.
Files: 1
3: Abstract 1: Improvement of experimental mouse models in Inflammatory Bowel Diseases using flexible video endoscopic colon evaluation
Year: 2016
Source: 2nd Y-ECCO Basic Science Workshop
Authors: Gay C.
Animal models, colonoscopy
Files: 1
3: Biologicals
Year: 2016
Source: 5th S-ECCO IBD Masterclass
Authors: Sandborn W.
perianal disease, anti TNF agents
Files: 1
3: Clinical and endoscopic features of IBD
Year: 2016
Source: 1st H-ECCO IBD Masterclass
Authors: Irving P.
disease activity indices Crohn's Disease, Ulcerative Colitis
Files: 1
3: Haematopoietic stem cell transplantation
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Salas A., Ricart E.
Stem cell transplantion, Crohn's Disease
Files: 1
3: Health literacy
Year: 2016
Source: 10th N-ECCO Network Meeting
Authors: Sorensen K.
Files: 1
3: How to optimise recruitment to clinical trials in IBD
Year: 2016
Source: 1st School for Clinical Trialists
Authors: Hart A.
Last Modified: Wednesday, 15 March 2017, 4:30 PM by Vesna Babaja
Files: 1
3: IBD as an epithelial wound healing defect
Year: 2016
Source: Molecular aetiology of IBD
Authors: Neurath M.
epithelial cell
Files: 1
3: IBD: The role of the exposome
Year: 2016
Source: 14th IBD Intensive Advanced Course
Authors: Halfvarson J.
Last Modified: Friday, 16 April 2021, 2:11 PM by ECCO Administrator
environmental factors, Smoking, exposome
Files: 1
3: Infection and antibiotics
Year: 2016
Source: 3rd EpiCom Workshop
Authors: Duricova D.
Crohn's Disease, Ulcerative Colitis, environment
Files: 1
3: Microbiota and IBD
Year: 2016
Source: 1st D-ECCO Workshop
Authors: Seksik P.
faecal microbiota transplantation, microbiota, probiotic therapy
Files: 1
3: Personalising Paediatric IBD: Identification of high and low risk patients at diagnosis
Year: 2016
Source: 3rd P-ECCO Educational Course
Authors: Levine A.
paediatric, prognosis
Files: 1
3: Psychosocial implications of living with IBD
Year: 2016
Source: 7th N-ECCO School
Authors: Gaarenstroom J.
Quality of life (IBDQ), IBD nurse, Psychologist, Depression, Incontinence
Files: 1
3: Session 2: Patient reported outcomes measures. New data
Year: 2016
Source: 2nd Advanced ECCO: EduCational COurse for Industry
Authors: Bodger K.
CLINICAL ACTIVITY INDICES, OUTCOMES, PROGNOSIS
Files: 1
3rd Edition of Top Strategy Trials
Year: 2020
Source: Talking Heads
Authors: Krisztina Gecse, Johan Burisch
Created: Monday, 27 July 2020, 11:54 AM by Dauren Ramankulov
Last Modified: Wednesday, 2 June 2021, 12:25 PM by ECCO Administrator
3rd line rescue in Acute severe UC - safe and effective?
Year: 2019
Source: JCC Podcast
Authors: David T. Rubin et al.
Created: Monday, 2 September 2019, 4:22 PM by Dauren Ramankulov
Last Modified: Wednesday, 4 March 2020, 12:13 PM by Dauren Ramankulov

JCC Associate Editor Dr Tim Raine and Prof David Rubin discuss the latest data from the Chicago experience of using ciclosporin in patients with acute severe ulcerative colitis refractory to infliximab rescue therapy.

https://academic.oup.com/ecco-jcc/pages/podcast

40: Best abstract: Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate to severe Ulcerative Colitis: Results from two phase 3 randomised controlled trials
Year: 2016
Source: ECCO'16 Amsterdam
Authors: D'Haens G.
Tofacitinib, Ulcerative Colitis
Files: 1
41: Best abstract: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s Disease: Interim analysis from the phase 2 FITZROY study
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Vermeire S.
Filgotinib, JAK-inhibitors, Crohn's Disease
Files: 1
45: ECCO-ESCP Guidelines: Surgical Crohn's Disease
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Bemelman W.
Crohn's Disease, anti-TNF agents, colectomy, colorectal cancer surveillance, post operative complications, ileo caecal resection, enterocutaneous fistula, ileo-anal pouch anastomosis
Files: 1
46: Best abstract: Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate to severe Crohn’s Disease: Results of a Phase 2b randomised placebo-controlled trial
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Panés J.
Crohn's Disease, tofacitinib
Files: 1